Impact Factor
2.42
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.02
130 total citations
h5-index
15
h5 depth signal
Cited share
42.4%
56 of 132
Total citations
130
Citation footprint
Metric signal
1.14
External metric anchor
Self-citation
13.1%
17 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Australia
506
United Kingdom
30
United States
11
China
10
New Zealand
6
Citing Fields of Research
Virology
273
Antibiotic & Antibacterial Agents
194
Tropical Diseases
129
Healthcare Policy
121
Bacteriology
75
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,958
Articles tracked across the journal lifetime
Indexed publication set
132
56 cited publications
Last 12 months
82
6.8 publications/month
Open access share
100.0%
82 OA publications in the last year
Leading citing country
Australia
506 citing publications
Leading citing field
Virology
273 citing publications
Latest tracked publication
29 September 2026
10 recent records available
Coverage & Indexing History
v42, 2018-
v42, 2018-
Research Focus & Classification
Indexed Subjects
Antibiotic & Antibacterial Agents
Virology
Bacteriology
Tropical Diseases
Sexually Transmitted Diseases
Issuing & Sponsoring Bodies
issuing body
Australia. Office of Health Protection. Health Protection Policy Branch
Broad Categories
Communicable Diseases
Antibiotic & Antibacterial Agents
Virology
Tropical Diseases
Hepatitis
Bacterial Pathogenesis
MeSH Descriptors
Australia
Communicable Disease Control
Communicable Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.33321/cdi.2026.50.064
Open DOI
Understanding the role of toxigenic Corynebacterium diphtheriae in skin infections in northern Australia
Important uncertainties remain regarding the role of coinfection, asymptomatic carriage, and the contribution of toxigenic Corynebacterium diphtheriae to clinical disease. This Letter to the Editor highlights several key unanswered quest...
02
DOI 10.33321/cdi.2026.50.062
Open DOI
Multiple outbreaks of norovirus caused by persistent transmission in a hospitality setting in Victoria, Australia, 2023
This report describes unusually persistent transmission of norovirus in a hospitality setting in Victoria, Australia. In September 2023, the Victorian State Government Department of Health was notified of six gastroenteritis outbreaks as...
03
DOI 10.33321/cdi.2026.50.058
Open DOI
Surveillance for severe influenza, COVID-19, and RSV in patients admitted to sentinel Australian hospitals in 2025: the Influenza Complications Alert Network (FluCAN) and the Paediatric Active Enhanced Disease Surveillance (PAEDS) system
IntroductionInfluenza, coronavirus disease 2019 (COVID-19) and respiratory syncytial virus (RSV) are common acute respiratory infections and are a cause of significant morbidity and mortality. This report summarises the epidemiology of h...
04
DOI 10.33321/cdi.2026.50.051
Open DOI
Enhancing influenza surveillance in Australia using Google search data combined with machine learning
BackgroundTo effectively respond to acute respiratory infections such as influenza, timely information about the spread of disease is required. Surveillance methods that train machine learning models on Google Trends data have been devel...
05
DOI 10.33321/cdi.2026.50.040
Open DOI
Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2019–2022
This summary report on vaccine preventable diseases in Australia is the latest in a series of multi-year surveillance reports that bring together the three most important national sources of routinely-collected data on VPDs (notification...
06
DOI 10.33321/cdi.2026.50.022
Open DOI
Report of the National Influenza Surveillance Scheme, 2022–2023
This report describes influenza surveillance activities in Australia in 2022 to 2023. Data were extracted from several sources constituting the National Influenza Surveillance Scheme. Following the relaxation of public health and social ...
07
DOI 10.33321/cdi.2026.50.059
Open DOI
The first high pathogenicity avian influenza A(H5N1) clade 2.3.4.4b incursions in the Hunter New England region, New South Wales, Australia, June–July 2026
Two incursions of high pathogenicity avian influenza (HPAI) A(H5N1) clade 2.3.4.4b in vagrant birds were identified in the Hunter New England region of New South Wales, Australia on 28 June 2026 and 10 July 2026. These were the first det...
08
DOI 10.33321/cdi.2026.50.056
Open DOI
ATAGI targeted review 2025: Immunisation considerations for immunocompromised people in Australia
Vaccination plays a pivotal role in protecting people who are immunocompromised, and who may therefore be at increased risk of infectious diseases, including vaccine preventable diseases (VPDs). However, there are special challenges in c...
09
DOI 10.33321/cdi.2026.50.055
Open DOI
Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2026
The reference laboratories of the Australian Meningococcal Surveillance Programme (AMSP) report data on the number of cases of invasive meningococcal disease (IMD) confirmed by laboratory testing using culture and molecular based techniq...
10
DOI 10.33321/cdi.2026.50.054
Open DOI
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2025
As part of its role in the World Health Organization (WHO) Global Influenza Surveillance and Response System (GISRS), the WHO Collaborating Centre for Reference and Research on Influenza in Melbourne (the Centre) received 13,817 human in...
Bibliographical & Catalog Notes
Articles published as they become available and compiled into annual volumes.